Bruker

BRKR

Market cap $5.54B

Bruker stock climbs after securing $10M in federally funded NMR orders from top U.S. research institutions.

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced new orders for advanced Nuclear Magnetic Resonance (NMR) instrumentation from the New York Structural Biology Center (NYSBC), the University of Delaware and Northwestern University. Supported by the National Institutes of Health (NIH) and the National Science Foundation (NSF), these high-performance systems will enable leading research teams to pursue breakthroughs across a wide range of scientific research, dr.

Six new preferred stock and baby bond offerings were tracked, with yields ranging from 6.375% to 8.875%. Top-quality preferreds (Compliance Score 10) are trading at a 2.8% discount to par, offering a current yield of 6.7%. Investors can often buy new preferred IPOs at wholesale prices on the OTC, minimizing capital loss risk if prices drop.

Bruker Corporation 6.375 PREF SER A is a new 6.375% mandatory convertible preferred stock from Bruker, offering fixed income but closely tied to BRKR's common stock performance. Bruker's fundamentals have weakened, with declining performance and a dividend cushion that's thinner than ideal for preferred holders. Option-adjusted yield to maturity is unappealing versus peer term preferreds of comparable maturity, especially given the lack of 1940 Act protections.

Medical device and diagnostics company Bruker (BRKR -11.68%) wasn't looking like the cure for any investor's ailments on Wednesday. The stock was hit with an assertive sell-off from the market, leaving it with a nearly 12% price decline on the session.

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (“Bruker”) (Nasdaq: BRKR) today announced the pricing of its previously announced public offering of $600.0 million of 6.375% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share (the “Mandatory Convertible Preferred Stock”). Bruker has granted the underwriters a 30-day option to purchase up to an additional $90.0 million of Mandatory Convertible Preferred Stock. The offering is expected to close on or about September 8.

Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?

U.S. stock futures were mostly higher this morning, with the Nasdaq futures gaining around 150 points on Wednesday.

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (“Bruker”) (Nasdaq: BRKR) today announced it has commenced a public offering, subject to market and other conditions, of $600.0 million of Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share (the “Mandatory Convertible Preferred Stock”). Bruker expects to grant the underwriters a 30-day option to purchase up to an additional $90.0 million of Mandatory Convertible Preferred Stock, solely to cover over-allotments, if any.

Michael Burry, the legendary “Big Short” investor and founder of Scion Asset Management has revealed a substantial reshuffle in his Q2 2025 holdings, adding heavyweight names across healthcare, retail, biotech, and e-commerce while trimming his largest position.